Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-24 @ 4:49 PM
Study NCT ID:
NCT02945150
Status:
COMPLETED
Last Update Posted:
2020-06-09
First Post:
2016-10-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-05
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-21
First Submit QC Date:
None
Study First Post Date:
2016-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-10
Results First Submit QC Date:
None
Results First Post Date:
2020-02-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-19
Last Update Post Date:
2020-06-09
Last Update Post Date Type:
ACTUAL